Top Markets
Coin of the day
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Kedudukan dalam Saham #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Harga Saham
$93.80
Disegerakkan terakhir: 2025-04-28
Modal Pasaran
$2.68B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Aerovate Therapeutics, Inc. (AVTE)

Kategori

EPS untuk Aerovate Therapeutics, Inc. (AVTE)
EPS setakat June 2026 TTM: $-3.65K
Menurut laporan kewangan terkini dan harga saham Aerovate Therapeutics, Inc., EPS semasa syarikat (TTM) adalah $-3.65K. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-2.87 peningkatan berbanding EPS tahun 2022 iaitu $-2.10.
Sejarah EPS untuk Aerovate Therapeutics, Inc. dari 2019 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
2026 (TTM) $-3.65K 149,412.70%
2024 $-2.44 -14.98%
2023 $-2.87 36.67%
2022 $-2.10 12.30%
2021 $-1.87 -95.34%
2020 $-40.17 28,592.86%
2019 $-0.14 0.00%
EPS untuk syarikat atau pesaing yang serupa
Syarikat EPS Perbezaan EPS Negara
$17.32 -100.47%
US
$27.74 -100.76%
NL
$-7.98 -99.78%
US
$-5.29 -99.85%
AU
- -
CH